Roka Bioscience, Inc. To Present At The Bank of America Merrill Lynch 2015 Health Care Conference

WARREN, N.J., May 5, 2015 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens,  today announced that Paul G. Thomas will present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 12 at 8:00am PT. The conference will be held at Encore at the Wynn, Las Vegas NV.

A live webcast of the presentation will be available through the investor relations section of Roka Bioscience's website at http://rokabio.investorroom.com/. A replay of the webcast will be available following the event.

During the presentation, material information concerning the Company, its operations, strategies and prospects may be discussed.

About Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies.  For more information, visit http://rokabio.com.

Investor Contact:
Roka Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-present-at-the-bank-of-america-merrill-lynch-2015-health-care-conference-300078114.html

SOURCE Roka Bioscience, Inc.